Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

617
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
617
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lifetime Manipulation by Excitation Power in Lanthanide Core-Shell Nanocrystals Without Altering Composition.

Small (Weinheim an der Bergstrasse, Germany)·2026
Same author

Bright, Biocompatible NIR-II-Emitting I-VI Quantum Dots for Rapid Disease Diagnosis.

Accounts of chemical research·2026
Same author

Real-Time In Vivo Visualization of Tumor-Associated Macrophage Reprogramming Using a Nitric Oxide-Activatable NIR-II Nanoinducer.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

Micron-Scale 2D Antibody Arrays for HER2 Signaling Blockade and Cancer Therapy.

Journal of the American Chemical Society·2026
Same author

Lattice-Engineered Lanthanide Nanocrystals with Tunable Near-Infrared-IIb Lifetime.

Angewandte Chemie (International ed. in English)·2025
Same author

An Engineered Multivalent TMV Nanodisk Platform for Modulating Integrin Clustering and Cell Signaling.

Angewandte Chemie (International ed. in English)·2025

Related Experiment Video

Updated: Aug 12, 2025

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells
08:02

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells

Published on: September 23, 2021

2.6K

Multifunctional Nano-Biomaterials for Cancer Therapy via Inducing Enhanced Immunogenic Cell Death.

Qian Chen1,2,3, Chunyan Li1,2, Qiangbin Wang1,2

  • 1School of Nano-Tech and Nano-Bionics, University of Science and Technology of China, Hefei, 230026, China.

Small Methods
|January 27, 2023
PubMed
Summary

Nano-biomaterials offer a promising solution for enhancing cancer immunotherapy by improving targeted delivery of immunogenic cell death (ICD) inducers and overcoming the immunosuppressive tumor microenvironment.

Keywords:
biomaterialscancerimmunogenic cell deathimmunotherapynanotechnology

More Related Videos

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy
09:01

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy

Published on: May 22, 2020

3.2K
Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
14:20

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

16.8K

Related Experiment Videos

Last Updated: Aug 12, 2025

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells
08:02

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells

Published on: September 23, 2021

2.6K
Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy
09:01

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy

Published on: May 22, 2020

3.2K
Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
14:20

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

16.8K

Area of Science:

  • Oncology
  • Immunology
  • Nanotechnology
  • Biomaterials Science

Background:

  • Immunotherapy is a leading strategy for cancer treatment.
  • Immunogenic cell death (ICD) triggers anti-tumor immune responses, making it crucial for effective cancer immunotherapy.
  • Current ICD-based immunotherapies face challenges like targeted delivery, insufficient immune stimulation, and immunosuppressive tumor microenvironments.

Purpose of the Study:

  • To review the fundamental aspects of ICD, including its occurrence, processes, and detection.
  • To explore the application of nano-biomaterials in enhancing ICD for cancer immunotherapy.
  • To discuss the future prospects and challenges of nanotechnology in ICD-based cancer therapy for clinical translation.

Main Methods:

  • Literature review of ICD mechanisms and detection methods.
  • Analysis of nano-biomaterial strategies for enhancing ICD.
  • Investigation of mechanisms and approaches to boost ICD via nanotechnology.
  • Discussion of clinical translation challenges and opportunities.

Main Results:

  • Nano-biomaterials possess unique nanoscale properties beneficial for overcoming limitations in ICD-mediating immunotherapy.
  • Specific nano-biomaterial strategies have been identified to enhance ICD induction and antitumor immunity.
  • Targeted delivery systems and modulation of the tumor microenvironment are key areas where nanotechnology shows promise.

Conclusions:

  • Nano-biomaterials represent a significant advancement in overcoming current hurdles in ICD-based cancer immunotherapy.
  • Further research and development are needed to translate these nanotechnological approaches into effective clinical treatments.
  • Nanotechnology holds substantial potential for improving the efficacy of cancer immunotherapy through enhanced ICD.